myTomorrows
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Netherlands · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Anthony Fokkerweg 61, Amsterdam, North H...Phone Number
+31 885253888Website
www.mytomorrows.comRevenue
$26.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About myTomorrows
myTomorrows aids patients in discovering and accessing treatments by connecting them with clinical trials and expanded access programs. The company supports BioPharma organizations by providing clinical trial recruitment and expanded access management services. Their offerings include patient-centric solutions and real-world data services to enhance treatment access. Targeting patients, healthcare professionals, and BioPharma entities, myTomorrows strives to empower individuals facing serious diseases with comprehensive treatment options.Explore more
myTomorrows Org Chart
VA
Data Scientist & Intern
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is myTomorrows your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when myTomorrows launches new products
Check out if myTomorrows is spiking on competitors!
Check if myTomorrows has recently received funding, and reach out quickly before it becomes old news!
myTomorrows, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if myTomorrows had a recent Job posting/layoffs
Funding: Get notified immidiatlly once myTomorrows has new funding data
Earning: See what the market has to say on myTomorrows recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at myTomorrows
Recommended Actions
Reach out to Masked Content who joined myTomorrows as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
myTomorrows is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
myTomorrows is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about myTomorrows.
myTomorrows financials insights
Gather financial insights about myTomorrows, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Angel/Seed
$2.2M
Unspecified
$5.6M
2017
Private Equity
$10.5M
2025
Private Equity
$29M
myTomorrows Tech Stack
A closer look at the technologies used by myTomorrows
See more technologies
Most Recent Scoops
Open Position
Open Position
Hiring Plans
myTomorrows has more open roles in Sales than it has had at any time in the past 12 months. Technologies mentioned include: HubSpot.
Hiring Plans
Open Position
Open Position
myTomorrows News & Media
myTomorrows and Rare Disease Research Partner to Improve Access to Rare Disease Clinical Trials
The collaboration is designed to increase trial visibility, support more structured referrals from community and specialist care settings, and improve coordination for patients, families, and referring providers AMSTERDAM and ATLANTA, April 16, 2026 /PRNewswire/ -- myTomorrows, a health...myTomorrows and CUN partner on AI-assisted patient trial matching
The partnership brings an AI-driven eligibility support system into current clinical workflows.myTomorrows and ClĂnica Universidad de Navarra Partner to Advance AI-Powered Clinical Trial Infrastructure in Spain
The collaboration marks myTomorrows' first large-scale site partnership in Spain, bringing AI-supported patient–trial matching and streamlined referral management to one of Europe's leading clinical research institutions. AMSTERDAM, March 26, 2026 /PRNewswire/ -- myTomorrows, a global...Sentynl Selects myTomorrows to Lead Managed Access Program
Reinforcing its commitment to rare disease treatment access, Sentynl is transitioning its program to myTomorrows patient-centric platform. AMSTERDAM, Dec. 10, 2025 /PRNewswire/ -- Sentynl Therapeutics, Inc. ("Sentynl"), a U.S.-based biopharmaceutical company wholly-owned by Zydus...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding myTomorrows
Sign Up For FreeTo access detailed company insights
myTomorrows aids patients in discovering and accessing treatments by connecting them with clinical trials and expanded access programs. The company supports BioPharma organizations by providing clinical trial recruitment and expanded access management services. Their offerings include patient-centric solutions and real-world data services to enhanc... Read More
